Organogenesis (ORGO)

Last Closing Price: 2.74 (2025-05-30)

Receiveable Turnover (Quarterly)

Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable

Organogenesis (ORGO) had Receiveable Turnover of 0.84 for the most recently reported fiscal quarter, ending 2025-03-31.

Figures for fiscal quarter ending 2025-03-31
Income Statement Financials
$86.69M
$-21.59M
$23.72M
$62.97M
$113.44M
$-26.75M
$0.96M
$-25.78M
$-25.78M
$-18.84M
$-18.84M
$-18.84M
$-18.84M
$-26.75M
$-20.46M
126.30M
126.30M
$-0.17
$-0.17
Balance Sheet Financials
$268.16M
$75.52M
$199.23M
$467.39M
$65.05M
$0.41M
$159.44M
$224.49M
$242.90M
$202.50M
$242.90M
126.85M
Cash Flow Statement Financials
$-19.93M
$-3.63M
$-2.06M
$136.15M
$110.53M
$-25.62M
$3.37M
--
--
Fundamental Metrics & Ratios
4.12
--
--
0.00
0.01
72.64%
-30.85%
-30.85%
--
-29.74%
-24.91%
$-23.56M
--
--
--
0.19
0.81
Receiveable Turnover
0.84
107.26
-7.76%
-9.30%
-4.03%
-7.74%
$1.91
$-0.19
$-0.16